Alendronate-loaded microparticles for improvement of intestinal cellular absorption

References

• Anić B, Grazio S. (2006). Current osteoporosis treatment: reasons for adding vitamin D to alendronate. Reumatizam, 53, 63–65.
   PubMedGoogle Scholar
• Birnbaum DT, Brannon-Peppas L. (2003). Microparticle Drug Delivery Systems, Totowa, NJ: Humana Press.
   Google Scholar
• Doclane V, Vilivalam VD. (1998). Pharmaceutical application of chitosan. Pharm Sci Technol Today, 1, 246–253.
   Google Scholar
• Ehtezazi T, Washington C, Melia CD. (1999). Determination of the internal morphology of poly(d,l-lactide) microspheres using stereological methods. J Control Release, 57, 301–314.
   PubMed Web of Science ®Google Scholar
• Ehtezazi T, Washington C. (2000). Controlled release of macromolecules from PLA microspheres using porous structure topology. J Control Release, 68, 361–372.
   PubMed Web of Science ®Google Scholar
• Ekelund K, Osth K, Pahlstorp C, Bjork E, Ulvenlund S, Johansson F. (2005). Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on Caco-2 cell monolayers and pig nasal mucosa. J Pharm Sci, 94, 730–744.
   PubMed Web of Science ®Google Scholar
• Furubayashi T, Kamaguchi A, Kawaharada K, Masaoka Y, Kataoka M, Yamashita S, Higashi Y, Sakane T. (2007). Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs. Biol Pharm Bull, 30, 1007–1010.
   PubMed Web of Science ®Google Scholar
• Graham D. (1998). Excess gastric ulcers are associated with alendronate therapy. Am J Gastroenterol, 93, 1395–1396.
   PubMed Web of Science ®Google Scholar
• Graham D, Malaty H. (1999). Alendronate gastric ulcers. Aliment Pharmacol Ther, 13, 515–519.
   PubMed Web of Science ®Google Scholar
• Graham DY. (2002). What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci, 47, 1665–1678.
   PubMed Web of Science ®Google Scholar
• Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. (2009). Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm, 381, 205–213.
   PubMed Web of Science ®Google Scholar
• Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. (1996). Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm, 145, 246–253.
   Google Scholar
• Hussain MR, Maji TK. (2008). Preparation of genipin cross-linked chitosan–gelatin microcapsules for encapsulation of Zanthoxylum limonella oil (ZLO) using salting-out method. J Microencap, 25, 414–420.
   PubMed Web of Science ®Google Scholar
• Jain RA. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21, 2475–2490.
   PubMed Web of Science ®Google Scholar
• Karamustafa F, çelebi N. (2008). Development of an oral microemulsion formulation of alendronate: effects of oil and co-surfactant type on phase behaviour. J Microencap, 25, 315–323.
   PubMed Web of Science ®Google Scholar
• Kimmel DB. (2007). Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphophonates. J Dent Res, 86, 1022–1033.
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. (1992). In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm, 78, 43–48.
   Web of Science ®Google Scholar
• Lufkin E, Argueta R, Whitaker MD, Cameron AL, Wong VH, Egan KS. (1994). Pamidronate: an unrecognized problem in gastrointestinal tolerability. Osteopor Int, 4, 320–322.
   PubMed Web of Science ®Google Scholar
• Maconi G, Porro G. (1995). Multiple ulcerative esophagitis caused by alendronate. Am J Gastroenterol, 90, 1889–1890.
   PubMed Web of Science ®Google Scholar
• Mao S, Germershaus O, Fischer D, Linn T, Schnepf R, Kissel T. (2005). Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm Res, 22, 2058–2068.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. (2009). Polymer-based nanocapsules for drug delivery. Int J Pharm, 385, 113–142.
   PubMedGoogle Scholar
• Perugini P, Genta I, Conti B, Modena T, Pavanetto F. (2001). Long-term release of clodronate from biodegradable microspheres. AAPS PharmSci Tech, 2, E10.
   PubMedGoogle Scholar
• Porras A, Holland S, Gertz B. (1999). Pharmacokinetics of alendronate. Clin Pharmacokinet, 36, 315–328.
   PubMed Web of Science ®Google Scholar
• Ringe JD, Farahmand P, Schacht E, Rozehnal A. (2007). Superiority of a combined treatment of alendronate and alfacalcidol compared to the combination of alendronate and plain vitamin D or alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int, 27, 425–434.
   PubMed Web of Science ®Google Scholar
• Sadeghi AMM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F. (2008). Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm, 70, 270–278.
   PubMed Web of Science ®Google Scholar
• Sakuma S, Matsumoto T, Yamashita S, Wang Y, Lu ZR. (2007). Conjug-ation of poorly absorptive drugs with mucoadhseive polymers for the improvement of oral absorption of drugs. J Control Release, 123, 195–202.
   PubMed Web of Science ®Google Scholar
• Samdancioglu S, Calis S, Summu M, Hincal AA. (2006). Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis. Drug Dev Ind Pharm, 32, 473–481.
   PubMed Web of Science ®Google Scholar
• Singh J, Pandit S, Bramwell VW, Alpar HO. (2006). Diphtheria toxoid loaded poly- (ϵ-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods, 38, 96–105.
   PubMed Web of Science ®Google Scholar
• Tenenbaum H, Shelemay A, Girard B, Zohar R, Fritz P. (2002). Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnotic uses. J Periodon, 73, 813–822.
   PubMed Web of Science ®Google Scholar
• Tian J, Yu J, Sun X. (2008). Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus). Vet Immun Immunopath, 126, 220–229.
   PubMed Web of Science ®Google Scholar
• Trickler W, Nagvekar AA, Dash AK. (2008). A novel microparticle formulation for sustained paclitaxel delivery. AAPS PharmSci Tech, 9, 486–493.
   PubMed Web of Science ®Google Scholar
• Viswanathan NB, Thomas PA, Pandit JK, Kulkarni MG, Mashelkar RA. (1999). Preparation of non-porous microspheres with high entrapement efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. J Control Release, 58, 9–20.
   PubMed Web of Science ®Google Scholar
• Weidenauer U, Bodmer D, Kissel T. (2003). Microencapsulation of hydrophilic drug substance using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of pamidronate di-sodium salt. J Microencap, 20, 509–524.
   PubMed Web of Science ®Google Scholar
• You SK, Kwon HH, Lee JM, Shin SC, Cho CW. (2009). Studies on the formation of hydrophobic ion-pairing complex of alendronate. Arch Pharm Res, 32, 1055–1060.
   PubMed Web of Science ®Google Scholar